The Moderna HIV vaccine trials are underway
Last week, Moderna made a groundbreaking announcement: Human trials for the experimental HIV vaccine are officially underway.
Together with the nonprofit scientific research organization International AIDS Vaccine Initiative, Moderna has developed a vaccine that is designed to send HIV antigens to a recipient’s body in the hopes that it induces an immune response.
By Jan. 27th, 2022, the two companies have inoculated their first human candidates.“We are tremendously excited to be advancing this new direction in HIV vaccine design with Moderna’s mRNA platform”, said Mark Feinberg, M.D., Ph.D., president and CEO of IAVI. “The search for an HIV vaccine has been long and challenging, and having new tools in terms of immunogens and platforms could be the key to making rapid progress toward an urgently needed, effective HIV vaccine”.How significant is this development to the long fight towards ending HIV?
Keep reading to find out.RELATED: FDA approves injectable form of PrEP given every two monthsHIV, or the human immunodeficiency virus, is a virus that affects the immune system, destroying CD4 or T cells in its wake.
